Algerian delegates assess their EuroMed Road Safety Pilot Project

Back to news


Continuing the series of country workshops in the EuroMed Road Safety project, on December 11, two delegates representing Algerian police and civil defence travelled to Beirut for a full day workshop to review the progress of their national pilot project.

The internal review tool developed in cooperation with IFRC PMer department was presented to the delegates, and with assistance from GRSP experts, it was adapted to their EuroMed Road Safety Pilot project ‘Controlling Speed in the Wilaya of Setif’.

Setif, an eastern wilaya located in eastern Algeria, ranks second in terms of population. It is an important financial and commercial hub. But Setif is infamous for its high number of road crashes leading to deaths and injuries. According to the available data, these casualties are caused mostly by speed and improper driver behaviour.

Launched in October 2013, the project has taken many positive steps forward, however there is still much to do beyond the conclusion to the EuroMed programme. During the workshop, traffic crash data was analysed, milestones reviewed and a study was undertaken on actions taken, actions untaken, and what challenges lie ahead for the continuation of the project. By the end of the workshop, the delegates left with a clear vision of how to progress beyond the support of the EuroMed programme, and took with them a number of resources, including the internal review tool, WHO Good Practice Manuals and a raft of GRSP-developed support material.

Algeria is the 4th country to conduct such an evaluation of its EuroMed Road Safety national pilot project after Tunisia, Lebanon and Palestine.

Together we can save millions of lives.
Become a member

Sign up for our newsletter

Marketing Permissions
Please select all the ways you would like to hear from Global Road Safety

You can unsubscribe at any time by clicking the link in the footer of our emails or by contacting For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.
Learn more about Mailchimp's privacy practices here.